Wednesday, February 23, 2022

Fw: (LML) Paradigm shift: how leprosy workers lost their skills and leprosy became an NTD

 
Leprosy Mailing List – February 23,  2022

 

Ref.:  (LML) Paradigm shift: how leprosy workers lost their skills and leprosy became an NTD

 

From:  Pranab Kumar Das, Birmingham, UK

 

Dear Pieter and colleagues,

 

 I enjoyed reading communications by Ben /Deepak (LML, February 20, 2022)..

 

The bottom line of these two exchanging communications is "disappearing clinical knowledge of Leprosy" and "gradual erosion of dedicated leprosy patients carers by invading technocrat administrators" are to blame in lingering leprosy as a public health problem.

 

Did I understand correctly? 

 

Sincerely

 

Pranab Kumar Das


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/7f02d3ae-55e6-44a0-9dd8-0939073415a7n%40googlegroups.com.

Monday, February 21, 2022

Fw: Ref.: (LML) Virtual LRI Spring Meeting 2022: Thursday 7 and Friday 8 of April 2022, 13:30 – 17:00 (CET)

 

 

 
Leprosy Mailing List – February 21,  2022

 

Ref.:  (LML) Virtual LRI Spring Meeting 2022: Thursday 7 and Friday 8 of April 2022, 13:30 – 17:00 (CET)

From:  Leprosy Research Initiative, Amsterdam, the Netherlands

 

Dear Pieter and colleagues,


Thursday 7 and Friday 8 of April 2022, 13:30 – 17:00 (CET)


The LRI Spring Meeting is an annual event that brings together the LRI Scientific Review Committee, LRI Steering Committee, LRI funded research groups as well as LRI partners, associate partners and co-financiers. During the meeting, researchers will present progress updates and results of their LRI funded projects. Also, the principal investigators of R2STOP (The Research to Stop Neglected Tropical Diseases Transmission Initiative) funded research projects will join the meeting and share their research findings.


For the second time the Spring Meeting will be organised as an online event – which allows us to open up the meeting to external participants - persons with a keen interest in leprosy research who wish to attend but are not otherwise invited.


The meeting also offers opportunities to virtually network with and learn from fellow researchers through network carousels (speed dates), 1-on-1 chats, and video calls.


We will soon share more information about the programme of this event and the registration procedure.


Updates will also be available on our website: www.leprosyresearch.org.


Kind regards,


Leprosy Research Initiative


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/34a66ada-d983-41b7-8f14-c85fb772f088n%40googlegroups.com.

Sunday, February 20, 2022

Fw: Ref.: (LML) Paradigm shift: how leprosy workers lost their skills and leprosy became an NTD

 
Leprosy Mailing List – February 20, 2022

 

Ref.:  (LML) Paradigm shift: how leprosy workers lost their skills and leprosy became an NTD

 

From:  Ben Naafs, Munnekeburen, the Netherlands


Dear Pieter,


I would like to emphasize the "cri de Coeur" of Henk Eggens in LML dd January 4, 2022 , where he shared his observation of the quickly disappearing knowledge and clinical skills in leprosy in the field and even at central management level. In a presentation on infoHansen https://bit.ly/32V6Fpw  , he analyses the reasons and provides suggestions for improvement.


The most important way to arrive at a solution, he argues, is to find the root of a problem. As an example, he uses a patient with an undiagnosed leprosy reaction. An example also shown by Salvatore Noto in LML (LML – January 7, 2022). His method works with why's. This is a way of solving problems and it's the way many people think unknowingly. But it is important to become aware of the way you arrive to an answer. His answer on this observation was: " it is the political commitment".


I fully agree with him. In the 1980th, over 40 years ago , the knowledge to prevent and treat leprosy was present and with the introduction of MDT expanding and increasing in the field. Twenty-five years ago, the patients were better off than at present. What went wrong and why was the political commitment lost?

There are two important reasons:

  • The first was the responsibility of the WHO, because it needed new publicity after the elimination of smallpox in 1980. The fight against leprosy went well at that time and leprosy was "chosen". It was decided to eliminate leprosy. But with the way the administration of the implementation was done, such an elimination was not possible within the time until the year 2000. As a result, because the goal must be reached, definitions were changed, treatments shortened, patients taken off the books, and leprosy control projects felt pressured to report fewer and fewer new patients. Yet it was not possible to eliminate leprosy as a public health problem in the year 2000 and the period to achieve it was extended to 2005 and lo and behold, it was achieved worldwide.

During this period, the emphasis came on early diagnosis to stop the transmission and not so much on treatment other than providing MDT. (Just to remember: the main objectives of the leprosy control program before were to cure people with leprosy, to stop the transmission of the infection and to prevent disabilities).

 

  • Secondly after the year 2000, governments concluded that leprosy control programs could stop and integrated in general health care. Clinical leprosy teaching was neglected because it was expected that science would take over and they had many other problems. After that time the emphasis of WHO and ILEP was directed to the disabled leprosy patients and their introduction in society, a good argument to ask for contributions from the public.

 

For experienced leprosy workers it became less interesting because more and more the emphasis went from clinical skills and skin smears to serological laboratory diagnosis and later PCR's. Much of the available money and attention was directed to this way. Clinical diagnosing and the clinical skills in follow-up were neglected. Experienced leprosy workers and supervisors were assigned to do other jobs as well and went to more profitable fields like TB and HIV programmes. Thus, many left the field of leprosy control.


When it was noticed that patients were diagnosed late and therefor the disability among the diagnosed patients increased and the percentage children went up, stigma was blamed. To concerned people, it was obvious that there was hardly clinical knowledge left, except as Henk Eggens mentioned in a few centres of excellence. Most of the supervisors with clinical knowledge were gone and the health worker could not get teaching on the job anymore. The supervisor had become an administrator and leprosy a Neglected Tropical Disease. Vertical lines for advice and referral had disappeared or became for disadvantaged patients impossible to access.


With teledermatology and smartphones the concerned try at present to fill the gaps. But for this you need time and knowledge too. Moreover, you need experts to give advice. There are so few left that it may have become impossible. ILEP and WHO involve administrators, epidemiologists, immunologists, infectiologists, public health specialists, psychologists but no in the field experienced leprologists to manage leprosy. These leprologists you need to diagnose complications in time and treat appropriately. Giving care and prevent complications will bring patients to come forward in time, because they will notice that they get the proper attention. Then pictures of deformity are not anymore to bring stigma about.

 

Ben

 


Dear Ben,


I am not commenting specifically on your write up, but my comment is more general that can apply partly to what Henk had written and what you are saying. I feel that in some ways, talking about the past, before pre-1980s and even 1990s, is like talking of another world. It is not just leprosy diagnosis and treatment have changed, the whole world has changed and in ways which seem incredible.


Just think of leprosy associations - all their worlds of big fund collections, doctors, and hospitals everywhere, missionaries - everything is gone. I have seen the changes in AIFO, it is a completely different organisation working very differently than even 15 years ago. Countries have lost their health budgets and recent Covid pandemic has highlighted fault lines in such a stark way.


We talk of PHC and universal health access - leprosy would need to find a place somewhere inside there. But I don't think that we have yet renewed our ideas of PHC and universal access that can fit in this new world. I feel that we all are still enclosed in the old way of thinking, and we have difficulties in imagining how to change with this new world.


In Asia and Americas and increasingly also in Africa, people look for everything on internet, through Google or YouTube. In a way LML takes advantage of that new world, but how can doctors, health workers and patients themselves use the new technologies to learn and provide services for leprosy is a key question.

As I said, it is not a specific comment but a more general one.


Warm regards,


Sunil Deepak

 


Dear Sunil,


I fully agree with what you write: my comments are too cramped, and I realize that. The World and its mentality have changed indeed, particularly into controlling the people who do the actual work. The working force has to surrender to "administrators" whose knowledge on organizing the work may be excellent, but who miss the potential to do the actual work themselves. Even if they know how to perform, they miss the skill. Therefore, they are no good in teaching these skills. They know so much that they have to concentrate on one subject, e.g. serology, epidemiology, etc., and applying that in the field. But that only theoretically, since they cannot do the work in the field because they lack the skills. They will tell others to do it and then control them and check on them. They are relatively better paid and more appreciated. Thus, if you as a "worker" want to move up you need to develop the ability to control and can forget your skills.


In this process I will not mention the empathy that has disappeared. It's gone because if someone makes mistakes and you as a controller don't punish it, you're not doing your job right. The missionary thoughts are laughable. Peace corps? Even Doctors without Borders is being run by administrators, and clinicians turned to administrators.


It is like the Covid epidemy run by administrators and even those who are clinicians turn to administrators. For the patients there are still workers but exploited for the goal for which we have no definition.


Indeed, we as moderators of LML and our writers are part of it. We write it for the patients and for the workers. But do we? Or do we only want to show what goes wrong, our excuse being we are involved in other things and become too old to do it ourselves.


Ben


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/8f34f491-f625-4989-8bc3-ffd504a4702en%40googlegroups.com.

Wednesday, February 16, 2022

Fw: Ref.: (LML) 21st International Leprosy Congress – Hyderabad, India – 08-11th November 2022

 

 

Leprosy Mailing List – February 16,  2022

 

Ref.:  (LML) 21st International Leprosy Congress – Hyderabad, India – 08-11th November 2022

 

From:  Ben Naafs, Munnekeburen, the Netherlands

 

Dear Peter,


I think it is a good time to remember The LML members of the 21st International Leprosy Conference, Hyderabad, 8th -11th Nov-2022 I am sure you all are aware of this important forthcoming event. I was requested by the organizers P Narasimha Rao & Sujai Suneetha who wrote me on behalf of Organising & Scientific Committee 21st International Leprosy Congress- India https://www.ilc-india2022.com email:ilc2022india@gmail.com mobile: +91-9849044898


In the last meeting of the Organizing committee of 21st ILC it was decided that the information about this conference should be disseminated widely. It was also decided that for this purpose the office bearers of various associations, organizations should be sought to disseminate information and seek their support on this issue. It is an appeal to disseminate the information on 2Ist ILC to your international & national organisations and colleagues. The details on the congress are available on the website: https://www.ilc-india2022.com . For any further information you may contact the ILC secretariat at E-Mail: ilc2022india@gmail.com .


We would therefore request you to please share this information to your colleagues and friends and use your influence to contact the funding agencies if possible.


I as person look with anticipation too this congress which will focus on the "workers" in leprosy and its research.

 

Deo volente I will be present.


Regards


Ben



LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/7f4b6aba-bd42-4458-9fb4-106ec015765an%40googlegroups.com.

Tuesday, February 8, 2022

Fw: Ref.: (LML) Infolep monthly overview of new publications on leprosy - Feb '22


 

Leprosy Mailing List – February 09,  2022

 

Ref.:  (LML) Infolep monthly overview of new publications on leprosy - Feb '22 

 

From:  Anniek Akerboom, Amsterdam, the Netherlands

 



Dear colleagues, 

Last month we celebrated World Leprosy Day (WLD) and World NTD Day. All around the globe we have used our collective voice to speak up for 1.7 billion people who are affected by NTDs, including people affected by leprosy. The WLD theme was 'United for Dignity'. Go to the World Leprosy Day page at Infolep to get a glimpse of how we were united during WLD by clicking on the different links.

The World Health Organization has launched the first leprosy training course for health workers on OpenWHO. The online course is free of costs, self-paced and includes the epidemiology of leprosy, suspecting and referring new cases, diagnosis and treatment, leprosy reactions, prevention of disabilities and public health interventions. To find out more and for registration, go to OpenWHO .

Enjoy reading the latest publications on leprosy and have a look at the coming events below. Also, I would be happy to assist you with literature searches on Infolep.

Warm regards,

Anniek Akerboom

Infolep Coordinator
www.leprosy-information.org
a.akerboom@infolep.org
 

 



 



Highlighted


Feel free to contact me to receive full-text versions if these cannot be found through the Infolep portal

 



Pandemic and people's plight. Experiences that echoed across India.
Goswami S, Sarah N, Awasthi J. The Leprosy Mission Trust India. 2022
 

Development of a questionnaire to determine the case detection delay of leprosy: A mixed-methods cultural validation study.
de Bruijne ND, Urgesa K, Aseffa A, et al. PLoS neglected tropical diseases. PLoS neglected tropical diseases. 2022; 16 (1) : e0010038.
 

Case Detection Delay Questionnaire
De Bruijne ND, Urgesa K, Aseffa A, et al. PLoS neglected tropical diseases. 2022.
 

Improving the Health and Wellbeing of People Living With Neglected Tropical Diseases Through Rehabilitation and Assistive Technology
World Health Organization. 2021.

 



 



Leprosy & COVID-19

 



The impact of COVID-19 on the labour market for persons affected by Hansen's disease
CorrĂȘa de Sousa AC. Leprosy Review. Lepra. 2021; 92 (3) : 303-307.
 

Trigger of Type 2 Lepra reaction with acute foot drop following Covid-19 vaccination.
Panda A, Begum F, Panda M, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2022.
 

Application of the ARIMA Model to Predict Under-Reporting of New Cases of Hansen's Disease during the COVID-19 Pandemic in a Municipality of the Amazon Region.
da Cunha V, Botelho G, de Oliveira A, et al. International journal of environmental research and public health. 2021.
 

Impacto da pandemia de Covid-19 no atendimento ao paciente com hansenĂ­ase: estudo avaliativo sob a Ăłtica do profissional de saĂșde
Mendonça IMS, Eleres FB, Santos Silva EM, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (2) : e4111225459. 

 



 



New publications

 



Stakeholder perspectives on an integrated package of care for lower limb disorders caused by podoconiosis, lymphatic filariasis or leprosy: A qualitative study
Davies B, Kinfe M, Ali O, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (1) : e0010132.
 

A Quality of Life Study in Patients with Leprosy Using DLQI and WHOQOL-BREF Questionnaires.
Tare D, Viswanath V, Pai K, et al. Indian journal of dermatology. 2021; 66 (5) : 574. 
 

Effect of mental imagery on depression, anxiety and stress in instituitionalised leprosy patients – An experimental study
Alisha-Akbar-Dossa , Parag-Shrinivas-Ranade , Rahul-Nagendrasingh-Bisen. World Journal of Advanced Research and Reviews. GSC Online Press. 2021; 12 (3) : 296-303.
 

Mycobacterium leprae folP1 gene mutations among dapsone resistant patients in Sudan
Musa HAA, Samaan MA, Siddig H, et al. Leprosy Review. Lepra. 2021; 92 (3) : 269-275.
 

Efficacy of fluorescent microscopy versus modified Fite-Faraco stain in skin biopsy specimens of leprosy cases - a comparative study.
Kalagarla S, Alluri R, Saka S, et al. International journal of dermatology. 2022.
 

Transcriptomic Analysis of Stimulated Response in Peripheral Blood Mononuclear Cells Reveal Potential Biomarkers for Early Diagnosis of Leprosy.
Yuan Y, Liu J, You Y, et al. Frontiers in cellular and infection microbiology. 2021.
 

Standardization of SYBR Green-Based Real-Time PCR Through the Evaluation of Different Thresholds for Different Skin Layers: An Accuracy Study and Track of the Transmission Potential of Multibacillary and Paucibacillary Leprosy Patients.
Sevilha-Santos L, Cerqueira S, Gomes C. Frontiers in microbiology. 2021.
 

Can anti-PGL-I antibody isotypes differentiate leprosy contacts and leprosy patients?
Albuquerque A, Mateus C, Rodrigues R, et al. Pathogens and global health. 2022.
 

Histomorphological Correlation with Bacteriological Index in Leprosy Patients
Naik S, More S, Joshi S. Iranian Journal of Pathology. Farname, Inc.. 2022; 17 (1) : 48-55.
 

The immune-suppressive landscape in lepromatous leprosy revealed by single-cell RNA sequencing.
Mi Z, Wang Z, Xue X, et al. Cell discovery. 2022; 8 (1) : 2. 
 

Fine-Mapping of the Major Histocompatibility Complex Region Linked to Leprosy in Northern China 
Chi China.Zhang R, Cao L, Chen W, et al. Frontiers in genetics. 2021.
 

Correlated geometric models of order k and its application to intensive care unit and leprosy data
Souza R, Diniz CAR. Statistics in Medicine. Wiley. 2022.

 


Pediatric Leprosy Profile in the Postelimination Era: A Study from Surabaya, Indonesia.
Prakoeswa C, Reza N, Alinda M, et al. The American journal of tropical medicine and hygiene. 2022.
 

Panorama epidemiológico da Hanseníase, doença tropical negligenciada que assola o nordeste brasileiro
Ribeiro DM, Lima BVM, Marcos EAC, et al. Research, Society and Development. Research, Society and Development. 2022; 11 (1) : e23111124884
 

Perfil epidemiolĂłgico da hansenĂ­ase na Bahia e no municĂ­pio de Teixeira de Freitas
Rocha T, Pires L, Santana AL, et al. Associacao Sergipana de Ciencia. Scientia Plena. 2022.
 

Prednisolone adverse events in the treatment and prevention of leprosy neuropathy in two large double blind randomized clinical trials 
Post E, Wagenaar I, Brandsma W, et al. Leprosy Review. Lepra. 2021; 92 (3) : 236-246.
 

Follow-up assessment of patients with Pure Neural Leprosy in a reference center in Rio de Janeiro-Brazil.
Pitta I, Hacker M, Andrade L, et al. PLoS neglected tropical diseases. 2022; 16 (1) : e0010070. 
 

Prediction of the Occurrence of Leprosy Reactions Based on Bayesian Networks
Rodrigues RSDA, Heise EFJ, Hartmann LF, et al. Research Square Platform LLC. 2022.
 

Lepra reactions: A study of 130 cases from Pakistan.
Tabassum S, Zia M, Khoja A, et al. JPMA. The Journal of the Pakistan Medical Association. 2021; 71 (10) : 2317-2320.
 

Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy.
Goulart I, Santana M, da Costa W, et al. IDCases. 2022.
 

Risk factors for physical disability due to leprosy: a case-control study
VĂ©ras GCB, Lima JĂșnior JF, CĂąndido EL, et al. Cadernos SaĂșde Coletiva. FapUNIFESP (SciELO). 2021.
 

Platelet rich fibrin: A novel treatment for trophic ulcer in Hansen's disease.
Dorjay K, Tandon S, Singh A, et al. Tropical doctor. 2022.
 

Leprosy Relapse: a Retrospective Study on Epidemiological, Clinical and Therapeutics Aspects at a Brazilian Referral Center.
Nascimento A, Santos D, Antunes D, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2022.
 

The Effectiveness of Interactive Patient Education on Adherence to Leprosy Medications in an Ambulatory Care Setting Indonesia: A Randomized Control Trial
Nuryanti Y, Faidiban RH, Sombuk H, et al. Scientific Foundation SPIROSKI. Open Access Macedonian Journal of Medical Sciences. 2022; 10 (G) : 33-37.

 



 



 



Events

 



CORE group/ReLAB-HS Disability-Inclusive Health Webinar: Strengthening physical rehabilitation and assitive technology services
Recording

Global disability summit
16-17 Feb 2022 | Virtual

 


ILEP Conference
14-16 Mar 2022 | Virtual

21st International Leprosy Congress
9-11 Nov 2022
Hyderabad & Virtual

 



 



Links

 



Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
 

ALLF - Official website of the Association des Léprologues de Langue Française
 

LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
 

InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)

 


ILEP newsletter archive

GPZL newsletter archive

WHO Goodwill Ambassador's Leprosy Bulletin

Leprosy Review

Leprosy Review Repository (1928-2001)

Fontilles Revista de LeprologĂ­a

Indian Journal of Leprosy

Hansenologia Internationalis

 




GDPR & the Infolep newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can update your preferences or unsubscribe from this list at any time.

 


 



 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/7d1c96c9-c988-484a-9321-db7e6886ee47n%40googlegroups.com.

Monday, February 7, 2022

Fw: Ref.: (LML) Announcement of 21st International Leprosy Congress 2022- India

 

 
Leprosy Mailing List – February 7,  2022

 

Ref.:  (LML) Announcement of 21st International Leprosy Congress 2022- India

 

From:  P. Narasimha and Sujai Suneetha, Hyderabad, India

 

 

Dear Pieter,


The International Leprosy Congress (ILC) is an important global event to bring together academicians, scientists, researchers, Health care workers and key stakeholders in the field of leprosy together to discuss recent evidence from present evidence, research, experiences from national programmes and perspectives of different partner organizations including the persons affected by leprosy. It was decided at Manila ILC-2019  that the 21st ILC will be held in India in the year 2022.  I am happy to make the first communication to the members of LML about the 21st ILC through this mail and will be posting the updates regularly.


The 21st ILC is being jointly organized by the Indian Association of Leprologists (IAL), The Indian Association of Dermatologists, Venereologists & Leprologists (IADVL), the Central Leprosy Division (CLD), Ministry of Health and Family Welfare, Govt of India and under the auspices of the International Leprosy Association (ILA). The 21st ILC will be held from 8-11 November 2022 at Hyderabad, India as a HYBRID conference (with both physical conference and web-based sessions)  with more than 110 hours of scientific deliberations. The venue is HITEX Convention Centre, Hyderabad, India.


We on behalf of ILC Organising committees invite and welcome all the members of LML to the 21stILC. The details regarding the congress are available at the website https://www.ilc-india2022.com. Please note that the website will be periodically updated with the conference information.


Important dates:


Conference:


 7-8  November: Pre-congress meetings

 8th to 10th November 2022: Web-based conference: (5 pm -10 pm) 

9th to 11th November 2022: Physical conference (9am to 4.30 pm with live feed) 

11th November (5 pm to 9 pm): Closing ceremony and Fellowship dinner

 

Registration:

Early bird registration:  Open now and will close by 30th April, 2022        

Regular registration: 1st May  - 31st August, 2022       

Late/ Onsite registration:  1st September – 7th November, 2022   

 

Abstract submission: 

Opens on:  1st March, 2022

Closes on:  31st May, 2022. 

Information on the outcome of abstract submission: 15th June, 2022

 

The draft list of topics / scientific sessions is available at the website (to be updated). We invite and welcome members to organise to submit their important research work for presentation at this congress through the web portal from 1st March. The registration links at the website are already active. We look forward to the participation of all members of LML in this conference to make this congress a successful scientific event. We also invite you all  to Hyderabad, India to attend this congress physically. 


We will be communicating periodic updates. You are welcome to  write to us at email: ilc2022india@gmail.com

 

With best regards


P Narasimha Rao & Sujai Suneetha

On behalf of Organising & Scientific Committee
21st International Leprosy Congress- India

https://www.ilc-india2022.com

email:ilc2022india@gmail.com

mobile: +91-9849044898






LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/a5b1e075-9de6-4862-af5e-512be498425en%40googlegroups.com.

Friday, February 4, 2022

Fw: Ref.: (LML) WHO online courses


 

 

 
Leprosy Mailing List – February 4,  2022

 

Ref.:  (LML) WHO online courses

 

From:  Henk Eggens, Santa Comba DĂŁo, Portugal

 

 

Dear Pieter,

 

I would like to draw the attention of the LML readers to the following online courses. All were produced recently and offered by WHO.

1       ELearning modules on diagnosis and treatment for leprosy

 

This course is based on the WHO Guidelines for diagnosis, treatment and prevention of leprosy. Total Duration: 5-7 hours

Modules                                                  Estimated duration of learning

1. Suspect and referral                               15 minutes

2. Diagnosis of leprosy                              30 minutes

3. Counselling for leprosy                          30 minutes

4. Treatment for leprosy                            60 minutes

5. Reaction and neuritis in leprosy              60 minutes

6. Management of disabilities in leprosy     40 minutes

7. Self-care in leprosy                                40 minutes

8. Laboratory diagnosis                             40 minutes

 

URL (Internet access): http://labs.enablingdimensions.com/Leprosy/

 

2       One of a series of online courses on the OpenWHO website is on leprosy.



This course addresses the epidemiology of leprosy, suspect and refer, diagnosis and treatment, lepra reactions, prevention of disabilities and public health interventions.

The site claims a course duration of approximately two hours. In reality this may be 3-4 times longer.

Modules offered:

  • Module 1: Introduction
  • Module 2: Suspect and refer   
  • Module 3: Diagnosis and treatment
  • Module 3: Diagnosis and treatment
  • Module 4: Nerve Function Assessment (NFA)
  • Module 5: Lepra reactions
  • Module 5A: Lepra reactions: clinical features
  • Module 5B: Lepra reactions: management
  • Module 6: Prevention and management of disabilities due to leprosy
  • Module 6A: Prevention and management of disabilities due to leprosy: Consequences of nerve damage
  • Module 6B: Prevention and management of disabilities due to leprosy: Consequences of nerve damage
  • Module 7: Self-care of disabilities
  • Module 8: Laboratory diagnosis in field settings
  • Module 9: Post-Exposure Prophylaxis (PEP) 
  • Module 10: Public health interventions
  • Final Assessment 

URL: https://openwho.org/courses/NTDs-leprosy 

 

3       The OpenWHO course on tropical dermatology

 

This course provides an overview of skin diseases seen in the tropics with emphasis on diagnoses that are common or of medical/public health importance. The diseases are organized by presenting complaint. This is designed to reflect how clinicians evaluate patients: by clinical presentation rather than by aetiology of disease.

For each disease, the key clinical findings, aetiology, diagnosis and management are discussed.

The site claims a course duration of approximately five hours. In reality this may be 3-4 times longer.

The course is divided into 7 modules. The first module is a review of the terminology used to describe skin diseases; these are essential to know before proceeding with the rest of the course.

The next six modules are organized by presentation of illness:

·        Itch in the Tropics

·        Pigmentary Disorders

·        Enlarged Limbs

·        Cutaneous Nodules

·        Fever and Rash

·        Cutaneous Ulcers

 

URL: https://openwho.org/courses/NTDs-Tropical-dermatology

 

4       OpenWHO offers more courses

 

On various health, health management  and disease subjects (for instance NTDs ) and in various languages.

 

Best,

 

Henk Eggens

---
Henk Eggens

(henk.eggens@gmail.com)


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/leprosymailinglist/0fa4fc64-e61f-4380-bc21-2e41af5ae900n%40googlegroups.com.